Table 3 Associations of various insulin resistance indices with overall, stage I and stage II hypertension subtypes

TyG index

1.447 (1.149–1.823)

0.002

1.408 (1.061–1.869)

0.01

1.425 (1.107–1.833)

0.006

TG/HDL-C

1.025 (0.986–1.066)

0.21

1.017 (0.975–1.061)

0.43

1.021 (0.986–1.058)

0.24

METS-IR

1.475 (0.833–2.610)

0.18

1.510 (0.759–3.005)

0.24

1.565 (0.856–2.863)

0.14

ZJU index

1.007 (1.001–1.013)

0.03

1.002 (0.995–1.010)

0.54

0.997 (0.989–1.005)

0.99

Stage I hypertension

TyG index

1.317 (1.029–1.687)

0.02

1.218 (0.890–1.665)

0.21

1.337 (0.936–1.911)

0.11

TG/HDL-C

1.001 (0.949–1.055)

0.98

1.008 (0.953–1.065)

0.78

1.014 (0.952–1.080)

0.66

METS-IR

1.157 (0.624–2.147)

0.64

1.081 (0.502–2.328)

0.84

1.677 (0.711–3.953)

0.23

ZJU index

1.004 (0.997–1.012)

0.26

1.002 (0.992–1.011)

0.73

0.990 (0.975–1.005)

0.18

Stage II hypertension

TyG index

2.011 (1.351–2.994)

0.001

1.813 (1.207–2.721)

0.004

1.645 (0.956–2.830)

0.07

TG/HDL-C

1.053 (1.006–1.103)

0.02

1.034 (0.984–1.085)

0.18

1.023 (0.960–1.091)

0.48

METS-IR

3.001 (1.171–7.696)

0.02

2.850 (1.080–7.520)

0.03

1.258 (0.337–4.698)

0.73

ZJU index

1.009 (1.000–1.017)

0.03

1.003 (0.992–1.013)

0.62

1.001 (0.988–1.015)

0.86